The FDA is advising users of diabetes devices that rely on smartphones to deliver safety alerts to regularly check their ...

Today, the U.S. Food and Drug Administration is alerting patients of a safety concern regarding diabetes devices, such as continuous glucose monitors (CGMs), insulin pumps and automated insulin dosing ...

The FDA today issued an alert around a safety concern regarding diabetes devices that rely on smartphones to deliver critical safety alerts.

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

In a recent transaction, Justin B. Klee, Co-Chief Executive Officer of Amylyx Pharmaceuticals , Inc. (NASDAQ:AMLX), sold 11,855 shares of common stock. The company, currently valued at $246 million, ...

You've probably heard some rumblings about people switching to mushroom coffee in the morning. Unless you've made the switch ...

Useful health quote on the benefits of checking your blood glucose level on a basis to reduce risk of complications.